McDermott Will & Emery assisted Claris Ventures in the transaction. ALKemist Bio closed its EUR 6.9 million investment round to support a TCR cellular therapy for...
ALKemist Bio’s €6.9 Million Investment Round
MyMeta’s Round Financing Led by BroadVision Group
McDermott Will & Emery represented MyMeta in the transaction. MyMeta, a digital adoption platform developed to adapt to any application and configured to offer support in...